Z51.1 — Encounter for antineoplastic chemotherapy and immunotherapy
Z51.1 is a non-billable header ICD-10-CM code for encounter for antineoplastic chemotherapy and immunotherapy. It cannot be billed on its own: choose one of the more specific child codes below.
Excludes2 — not included here, but may coexist
The excluded condition is not part of this code, but a patient can have both. You may code both.
- encounter for chemotherapy and immunotherapy for nonneoplastic condition - code to condition
Excludes1 inherited from the categories above Z51.1
These are not written on Z51.1, but they bind it: a note on a category applies to every code beneath it. Billing Z51.1 with anything listed here is a denial.
Risk adjustment
Z51.1 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Code history
Z51.1 has not changed since FY2024 — no addition, revision or deletion across the three most recent ICD-10-CM releases.
Code to one of these instead Z51.1
2 child codes. Green means billable.
Related codes at this level
Codes that share Z51. If Z51.1 is not quite right, the correct code is usually one of these.
Questions about Z51.1
- Is Z51.1 a billable ICD-10-CM code?
- No. Z51.1 is a non-billable header code. Code to a higher level of specificity using one of its child codes.
- Where does Z51.1 sit in the tabular list?
- Factors influencing health status and contact with health services (Z00-Z99), in the block Encounters for other specific health care (Z40-Z53).
- What cannot be coded together with Z51.1?
- Z51.1 carries Excludes1 notes, which means the conditions they list can never be coded together with it on the same encounter. Some are written on the categories above Z51.1 (Z51) and apply to it just the same.